Skip to main content
Fig. 7 | Experimental Hematology & Oncology

Fig. 7

From: Blocking siglec-10hi tumor-associated macrophages improves anti-tumor immunity and enhances immunotherapy for hepatocellular carcinoma

Fig. 7

Blocking Siglec-10 produces synergistic benefits with PD-1 inhibitor. a Spearman correlation of the mRNA level of Siglec-10 and PD-1 in TCGA cohort. b Spearman correlation of the mRNA level of Siglec-10 and PD-L1 in TCGA cohort. c The synergistic effect of Siglec-10 Fc and pembrolizumab on the proportion of Annexin V+ PI+ epithelial cells in HCC samples (n = 20). d The synergistic effect of Siglec-10 Fc and pembrolizumab on the proportion of Ki-67+ epithelial cells in HCC samples (n = 20)

Back to article page

Experimental Hematology & Oncology

ISSN: 2162-3619

Contact us